Weight loss injections are typically prescribed to adults with a BMI of 30 or higher, or 27+ with weight-related health conditions such as type 2 diabetes, high blood pressure or high cholesterol
By combining careful assessment, clear communication, and evolving evidence, clinicians can reduce aspiration risk while maintaining optimal patient outcomes
The subcutaneous administration of growth hormone at the same injection site over a long period may result in local lipoatrophy
Here, we review this expanding field of research, focusing on the diversity of mechanisms that link glutamatergic signalling, postsynaptic action potentials and inhibitory synaptic strength
New research has found that semaglutide, a popular medication used to treat diabetes and obesity, may help protect kidney function in people, who have excess weight and cardiovascular disease
Our unique Dual-Action formula combines Reduced L-Glutathione with Selenium and Vitamin B6 in its active form (P5P)